Emma Palmer Foster
Direttore/Membro del Consiglio presso Discovery Park Ventures LLC
Posizioni attive di Emma Palmer Foster
Società | Posizione | Inizio | Fine |
---|---|---|---|
Chartered Institute of Public Relations
Chartered Institute of Public Relations Miscellaneous Commercial ServicesCommercial Services The Chartered Institute of Public Relations is a professional organization committed to professional standards and lifelong learning for public relations professionals. The organization is based in London, UK and is the world's only royal chartered body for public relations professionals. The British company offers professional development opportunities, networking events, and support for their members. The CEO of the non-profit company is Alastair McCapra. | Corporate Officer/Principal | 01/02/2011 | - |
Discovery Park Ventures LLC
Discovery Park Ventures LLC Investment ManagersFinance Discovery Park Ventures LLC (Discovery Park Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Seattle, Washington. | Direttore/Membro del Consiglio | 01/06/2022 | - |
Storia della carriera di Emma Palmer Foster
Precedenti posizioni note di Emma Palmer Foster
Società | Posizione | Inizio | Fine |
---|---|---|---|
College Hill Life Sciences Ltd.
College Hill Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services College Hill Life Sciences Ltd. provides public relation services. Its focus areas include financial public relations and investor relations, with specialist industry sector teams, corporate public relations, public affairs, branding, financial reporting and digital, risk and crisis management, employee engagement and strategic research consultancy. The company was founded by Sue Charles, Peter Colley and Katja Stout in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Sirigen Group Ltd.
Sirigen Group Ltd. Chemicals: Major DiversifiedProcess Industries Harnessing the power of novel light-harvesting polymeric materials, Sirigen's amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. The company's versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications. Its platform agnostic, enabling technology represents a quantum leap in detection capabilities, amplifying the sensitivity of a wide range of existing instrumentation and detection platforms by up to 100 fold. The company's technology is applicable to a diverse cross section of the biomedical industry including the $6billion drug discovery industry which can use it to test the efficacy of new drugs, the $12billion life sciences industry which can use Sirigen to develop new detection platforms, and the $35billion diagnostics industry, which can work with the company to optimise existing diagnostic techniques and to develop the next generation of diagnostic tools. Indeed the potential to deliver real time testing on miniaturised monitoring devices is close to reality. | Direttore/Membro del Consiglio | 01/02/2011 | - |
Formazione di Emma Palmer Foster
University of Oxford | Graduate Degree |
University of Durham | Masters Business Admin |
Statistiche
Distribuzione geografica
Regno Unito | 6 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Settori
Commercial Services | 3 |
Consumer Services | 3 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Sirigen Group Ltd.
Sirigen Group Ltd. Chemicals: Major DiversifiedProcess Industries Harnessing the power of novel light-harvesting polymeric materials, Sirigen's amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. The company's versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications. Its platform agnostic, enabling technology represents a quantum leap in detection capabilities, amplifying the sensitivity of a wide range of existing instrumentation and detection platforms by up to 100 fold. The company's technology is applicable to a diverse cross section of the biomedical industry including the $6billion drug discovery industry which can use it to test the efficacy of new drugs, the $12billion life sciences industry which can use Sirigen to develop new detection platforms, and the $35billion diagnostics industry, which can work with the company to optimise existing diagnostic techniques and to develop the next generation of diagnostic tools. Indeed the potential to deliver real time testing on miniaturised monitoring devices is close to reality. | Process Industries |
College Hill Life Sciences Ltd.
College Hill Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services College Hill Life Sciences Ltd. provides public relation services. Its focus areas include financial public relations and investor relations, with specialist industry sector teams, corporate public relations, public affairs, branding, financial reporting and digital, risk and crisis management, employee engagement and strategic research consultancy. The company was founded by Sue Charles, Peter Colley and Katja Stout in 2002 and is headquartered in London, the United Kingdom. | Commercial Services |
Chartered Institute of Public Relations
Chartered Institute of Public Relations Miscellaneous Commercial ServicesCommercial Services The Chartered Institute of Public Relations is a professional organization committed to professional standards and lifelong learning for public relations professionals. The organization is based in London, UK and is the world's only royal chartered body for public relations professionals. The British company offers professional development opportunities, networking events, and support for their members. The CEO of the non-profit company is Alastair McCapra. | Commercial Services |
Discovery Park Ventures LLC
Discovery Park Ventures LLC Investment ManagersFinance Discovery Park Ventures LLC (Discovery Park Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Seattle, Washington. | Finance |
- Borsa valori
- Insiders
- Emma Palmer Foster
- Esperienza